Lessons from immunogenomic analyses using RNA-sequencing - Trajanoski

2020年1月11日

A wide variety of cell types are involved during anti-tumor immune response which results in a highly complex tumor microenvironment (TME). RNA sequencing has emerged as a powerful tool for deciphering the TME. Watch this video clip to learn more about how RNA-sequencing can be used to advance our understanding of cancer biology and tumor progression. Speaker: Prof. Zlatko Trajanoski Biocenter, Division for Bioinformatics Medical University of Innsbruck To learn more visit our website: https://emea.illumina.com/areas-of-interest/cancer/research/sequencing-methods/cancer-rna-seq.html QB9145/9146 Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

この記事を共有します